{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T02:16:39Z","timestamp":1792808199064,"version":"4.5.0"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["K23GM151444"],"award-info":[{"award-number":["K23GM151444"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"DOI":"10.1007\/s00467-026-07487-0","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T01:23:37Z","timestamp":1784856217000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Pediatric sepsis\u2013associated acute kidney injury: leveraging pathophysiology for risk stratification and identification of treatable traits"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-1215-091X","authenticated-orcid":false,"given":"Imogen","family":"Clover-Brown","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3672-7960","authenticated-orcid":false,"given":"Dana Y.","family":"Fuhrman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4473-8376","authenticated-orcid":false,"given":"Natalja L.","family":"Stanski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,24]]},"reference":[{"key":"7487_CR1","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S2213-2600(18)30063-8","volume":"6","author":"C Fleischmann-Struzek","year":"2018","unstructured":"Fleischmann-Struzek C, Goldfarb DM, Schlattmann P et al (2018) The global burden of paediatric and neonatal sepsis: a systematic review. Lancet Respir Med 6:223\u2013230. https:\/\/doi.org\/10.1016\/S2213-2600(18)30063-8","journal-title":"Lancet Respir Med"},{"key":"7487_CR2","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1164\/rccm.201412-2323OC","volume":"191","author":"SL Weiss","year":"2015","unstructured":"Weiss SL, Fitzgerald JC, Pappachan J et al (2015) Global epidemiology of pediatric severe sepsis: the Sepsis Prevalence, Outcomes, and Therapies Study. Am J Respir Crit Care Med 191:1147\u20131157. https:\/\/doi.org\/10.1164\/rccm.201412-2323OC","journal-title":"Am J Respir Crit Care Med"},{"key":"7487_CR3","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1097\/01.PCC.0000149131.72248.E6","volume":"6","author":"B Goldstein","year":"2005","unstructured":"Goldstein B, Giroir B, Randolph A, International Consensus Conference on Pediatric Sepsis (2005) International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med 6:2\u20138. https:\/\/doi.org\/10.1097\/01.PCC.0000149131.72248.E6","journal-title":"Pediatr Crit Care Med"},{"key":"7487_CR4","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1001\/jama.2024.0179","volume":"331","author":"LJ Schlapbach","year":"2024","unstructured":"Schlapbach LJ, Watson RS, Sorce LR et al (2024) International consensus criteria for pediatric sepsis and septic shock. JAMA 331:665\u2013674. https:\/\/doi.org\/10.1001\/jama.2024.0179","journal-title":"JAMA"},{"key":"7487_CR5","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1097\/CCM.0000000000002007","volume":"44","author":"JC Fitzgerald","year":"2016","unstructured":"Fitzgerald JC, Basu RK, Akcan-Arikan A et al (2016) Acute kidney injury in pediatric severe sepsis: an independent risk factor for death and new disability. Crit Care Med 44:2241\u20132250. https:\/\/doi.org\/10.1097\/CCM.0000000000002007","journal-title":"Crit Care Med"},{"key":"7487_CR6","doi-asserted-by":"publisher","first-page":"e686","DOI":"10.1097\/PCC.0000000000002418","volume":"21","author":"MC Starr","year":"2020","unstructured":"Starr MC, Banks R, Reeder RW et al (2020) Severe acute kidney injury is associated with increased risk of death and new morbidity after pediatric septic shock. Pediatr Crit Care Med 21:e686\u2013e695. https:\/\/doi.org\/10.1097\/PCC.0000000000002418","journal-title":"Pediatr Crit Care Med"},{"key":"7487_CR7","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1007\/s00134-020-05940-8","volume":"46","author":"NL Stanski","year":"2020","unstructured":"Stanski NL, Cvijanovich NZ, Fitzgerald JC et al (2020) Severe acute kidney injury is independently associated with mortality in children with septic shock. Intensive Care Med 46:1050\u20131051. https:\/\/doi.org\/10.1007\/s00134-020-05940-8","journal-title":"Intensive Care Med"},{"key":"7487_CR8","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.2215\/CJN.00850122","volume":"17","author":"S Kuwabara","year":"2022","unstructured":"Kuwabara S, Goggins E, Okusa MD (2022) The pathophysiology of sepsis-associated AKI. Clin J Am Soc Nephrol 17:1050\u20131069. https:\/\/doi.org\/10.2215\/CJN.00850122","journal-title":"Clin J Am Soc Nephrol"},{"key":"7487_CR9","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.ccc.2020.11.010","volume":"37","author":"CL Manrique-Caballero","year":"2021","unstructured":"Manrique-Caballero CL, Del Rio-Pertuz G, Gomez H (2021) Sepsis-associated acute kidney injury. Crit Care Clin 37:279\u2013301. https:\/\/doi.org\/10.1016\/j.ccc.2020.11.010","journal-title":"Crit Care Clin"},{"key":"7487_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2025.1603392","volume":"12","author":"W Nian","year":"2025","unstructured":"Nian W, Tao W, Zhang H (2025) Review of research progress in sepsis-associated acute kidney injury. Front Mol Biosci 12:1603392. https:\/\/doi.org\/10.3389\/fmolb.2025.1603392","journal-title":"Front Mol Biosci"},{"key":"7487_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-025-05329-3","volume":"29","author":"W Wu","year":"2025","unstructured":"Wu W, Lan W, Jiao X et al (2025) Pyroptosis in sepsis-associated acute kidney injury: mechanisms and therapeutic perspectives. Crit Care 29:168. https:\/\/doi.org\/10.1186\/s13054-025-05329-3","journal-title":"Crit Care"},{"key":"7487_CR12","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1007\/s00134-023-07171-z","volume":"49","author":"NL Stanski","year":"2023","unstructured":"Stanski NL, Rodrigues CE, Strader M et al (2023) Precision management of acute kidney injury in the intensive care unit: current state of the art. Intensive Care Med 49:1049\u20131061. https:\/\/doi.org\/10.1007\/s00134-023-07171-z","journal-title":"Intensive Care Med"},{"key":"7487_CR13","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/S2213-2600(21)00461-6","volume":"10","author":"MV Maddali","year":"2022","unstructured":"Maddali MV, Churpek M, Pham T et al (2022) Validation and utility of ARDS subphenotypes identified by machine-learning models using clinical data: an observational, multicohort, retrospective analysis. Lancet Respir Med 10:367\u2013377. https:\/\/doi.org\/10.1016\/S2213-2600(21)00461-6","journal-title":"Lancet Respir Med"},{"key":"7487_CR14","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1007\/s00467-023-06133-3","volume":"39","author":"DY Fuhrman","year":"2024","unstructured":"Fuhrman DY, Stanski NL, Krawczeski CD et al (2024) A proposed framework for advancing acute kidney injury risk stratification and diagnosis in children: a report from the 26th Acute Disease Quality Initiative (ADQI) conference. Pediatr Nephrol 39:929\u2013939. https:\/\/doi.org\/10.1007\/s00467-023-06133-3","journal-title":"Pediatr Nephrol"},{"key":"7487_CR15","doi-asserted-by":"publisher","first-page":"c179","DOI":"10.1159\/000339789","volume":"120","author":"A Khwaja","year":"2012","unstructured":"Khwaja A (2012) KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract 120:c179\u2013c184. https:\/\/doi.org\/10.1159\/000339789","journal-title":"Nephron Clin Pract"},{"key":"7487_CR16","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/s41581-023-00683-3","volume":"19","author":"A Zarbock","year":"2023","unstructured":"Zarbock A, Nadim MK, Pickkers P et al (2023) Sepsis-associated acute kidney injury: consensus report of the 28th Acute Disease Quality Initiative workgroup. Nat Rev Nephrol 19:401\u2013417. https:\/\/doi.org\/10.1038\/s41581-023-00683-3","journal-title":"Nat Rev Nephrol"},{"key":"7487_CR17","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1016\/j.ekir.2021.04.022","volume":"6","author":"NL Stanski","year":"2021","unstructured":"Stanski NL, Wong HR, Basu RK et al (2021) Recalibration of the Renal Angina Index for pediatric septic shock. Kidney Int Rep 6:1858\u20131867. https:\/\/doi.org\/10.1016\/j.ekir.2021.04.022","journal-title":"Kidney Int Rep"},{"key":"7487_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-022-04070-5","volume":"26","author":"MR Atreya","year":"2022","unstructured":"Atreya MR, Cvijanovich NZ, Fitzgerald JC et al (2022) Integrated PERSEVERE and endothelial biomarker risk model predicts death and persistent MODS in pediatric septic shock: a secondary analysis of a prospective observational study. Crit Care 26:210. https:\/\/doi.org\/10.1186\/s13054-022-04070-5","journal-title":"Crit Care"},{"key":"7487_CR19","doi-asserted-by":"publisher","first-page":"e999","DOI":"10.1097\/CCM.0000000000004042","volume":"47","author":"C Nusshag","year":"2019","unstructured":"Nusshag C, Rupp C, Schmitt F et al (2019) Cell cycle biomarkers and soluble urokinase-type plasminogen activator receptor for the prediction of sepsis-induced acute kidney injury requiring renal replacement therapy: a prospective, exploratory study. Crit Care Med 47:e999\u2013e1007. https:\/\/doi.org\/10.1097\/CCM.0000000000004042","journal-title":"Crit Care Med"},{"key":"7487_CR20","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1097\/MCC.0000000000001090","volume":"29","author":"B McNicholas","year":"2023","unstructured":"McNicholas B, Akcan Arikan A, Ostermann M (2023) Quality of life after acute kidney injury. Curr Opin Crit Care 29:566\u2013579. https:\/\/doi.org\/10.1097\/MCC.0000000000001090","journal-title":"Curr Opin Crit Care"},{"key":"7487_CR21","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1159\/000363725","volume":"127","author":"FT Billings","year":"2014","unstructured":"Billings FT, Shaw AD (2014) Clinical trial endpoints in acute kidney injury. Nephron Clin Pract 127:89\u201393. https:\/\/doi.org\/10.1159\/000363725","journal-title":"Nephron Clin Pract"},{"key":"7487_CR22","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW et al (2016) The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 315:801\u2013810. https:\/\/doi.org\/10.1001\/jama.2016.0287","journal-title":"JAMA"},{"key":"7487_CR23","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1681\/ASN.2010040430","volume":"22","author":"DL Rosin","year":"2011","unstructured":"Rosin DL, Okusa MD (2011) Dangers within: DAMP responses to damage and cell death in kidney disease. J Am Soc Nephrol 22:416\u2013425. https:\/\/doi.org\/10.1681\/ASN.2010040430","journal-title":"J Am Soc Nephrol"},{"key":"7487_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/cc11652","volume":"16","author":"HR Wong","year":"2012","unstructured":"Wong HR, Salisbury S, Xiao Q et al (2012) The pediatric sepsis biomarker risk model. Crit Care 16:R174. https:\/\/doi.org\/10.1186\/cc11652","journal-title":"Crit Care"},{"key":"7487_CR25","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1097\/CCM.0000000000001852","volume":"44","author":"HR Wong","year":"2016","unstructured":"Wong HR, Cvijanovich NZ, Anas N et al (2016) Pediatric sepsis biomarker risk model-II: redefining the pediatric sepsis biomarker risk model with septic shock phenotype. Crit Care Med 44:2010\u20132017. https:\/\/doi.org\/10.1097\/CCM.0000000000001852","journal-title":"Crit Care Med"},{"key":"7487_CR26","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1164\/rccm.201911-2187OC","volume":"201","author":"NL Stanski","year":"2020","unstructured":"Stanski NL, Stenson EK, Cvijanovich NZ et al (2020) PERSEVERE biomarkers predict severe acute kidney injury and renal recovery in pediatric septic shock. Am J Respir Crit Care Med 201:848\u2013855. https:\/\/doi.org\/10.1164\/rccm.201911-2187OC","journal-title":"Am J Respir Crit Care Med"},{"key":"7487_CR27","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1097\/PCC.0000000000003589","volume":"25","author":"NL Stanski","year":"2024","unstructured":"Stanski NL, Zhang B, Cvijanovich NZ et al (2024) Diagnostic validation of the updated pediatric sepsis biomarker risk II for acute kidney injury prediction model in pediatric septic shock. Pediatr Crit Care Med 25:1005\u20131016. https:\/\/doi.org\/10.1097\/PCC.0000000000003589","journal-title":"Pediatr Crit Care Med"},{"key":"7487_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-023-04554-y","volume":"27","author":"MR Atreya","year":"2023","unstructured":"Atreya MR, Cvijanovich NZ, Fitzgerald JC et al (2023) Prognostic and predictive value of endothelial dysfunction biomarkers in sepsis-associated acute kidney injury: risk-stratified analysis from a prospective observational cohort of pediatric septic shock. Crit Care 27:260. https:\/\/doi.org\/10.1186\/s13054-023-04554-y","journal-title":"Crit Care"},{"key":"7487_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-023-04746-6","volume":"27","author":"NL Stanski","year":"2023","unstructured":"Stanski NL, Basu RK, Cvijanovich NZ et al (2023) External validation of the modified sepsis renal angina index for prediction of severe acute kidney injury in children with septic shock. Crit Care 27:463. https:\/\/doi.org\/10.1186\/s13054-023-04746-6","journal-title":"Crit Care"},{"key":"7487_CR30","doi-asserted-by":"publisher","DOI":"10.1097\/PCC.0000000000003789","author":"NL Stanski","year":"2025","unstructured":"Stanski NL, Zhang B, Ouyang J et al (2025) Derivation and validation of pediatric sepsis-associated acute kidney injury subphenotypes with prognostic relevance. Pediatr Crit Care Med. https:\/\/doi.org\/10.1097\/PCC.0000000000003789","journal-title":"Pediatr Crit Care Med"},{"key":"7487_CR31","doi-asserted-by":"publisher","unstructured":"Stanski NL, Zhang B, Ouyang J et al (2026) External validation, molecular signatures, and therapeutic relevance of pediatric sepsis-associated acute kidney injury subphenotypes. Crit Care Med 54:1680\u20131690. https:\/\/doi.org\/10.1097\/CCM.0000000000007135","DOI":"10.1097\/CCM.0000000000007135"},{"key":"7487_CR32","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1164\/rccm.201906-1197OC","volume":"202","author":"M Fiorentino","year":"2020","unstructured":"Fiorentino M, Xu Z, Smith A et al (2020) Serial measurement of cell-cycle arrest biomarkers [TIMP-2] \u00b7 [IGFBP7] and risk for progression to death, dialysis, or severe acute kidney injury in patients with septic shock. Am J Respir Crit Care Med 202:1262\u20131270. https:\/\/doi.org\/10.1164\/rccm.201906-1197OC","journal-title":"Am J Respir Crit Care Med"},{"key":"7487_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-023-04518-2","volume":"27","author":"N Pode-Shakked","year":"2023","unstructured":"Pode-Shakked N, Ceschia G, Rose JE et al (2023) Increasing angiotensin-converting enzyme concentrations and absent angiotensin-converting enzyme activity are associated with adverse kidney outcomes in pediatric septic shock. Crit Care 27:230. https:\/\/doi.org\/10.1186\/s13054-023-04518-2","journal-title":"Crit Care"},{"key":"7487_CR34","doi-asserted-by":"publisher","first-page":"3099","DOI":"10.1007\/s00467-023-05930-0","volume":"38","author":"NL Stanski","year":"2023","unstructured":"Stanski NL, Pode Shakked N, Zhang B et al (2023) Serum renin and prorenin concentrations predict severe persistent acute kidney injury and mortality in pediatric septic shock. Pediatr Nephrol 38:3099\u20133108. https:\/\/doi.org\/10.1007\/s00467-023-05930-0","journal-title":"Pediatr Nephrol"},{"key":"7487_CR35","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1038\/ki.2013.349","volume":"85","author":"RK Basu","year":"2014","unstructured":"Basu RK, Zappitelli M, Brunner L et al (2014) Derivation and validation of the renal angina index to improve the prediction of acute kidney injury in critically ill children. Kidney Int 85:659\u2013667. https:\/\/doi.org\/10.1038\/ki.2013.349","journal-title":"Kidney Int"},{"key":"7487_CR36","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/S2352-4642(17)30181-5","volume":"2","author":"RK Basu","year":"2018","unstructured":"Basu RK, Kaddourah A, Goldstein SL et al (2018) Assessment of a renal angina index for prediction of severe acute kidney injury in critically ill children: a multicentre, multinational, prospective observational study. Lancet Child Adolesc Health 2:112\u2013120. https:\/\/doi.org\/10.1016\/S2352-4642(17)30181-5","journal-title":"Lancet Child Adolesc Health"},{"key":"7487_CR37","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1097\/PEC.0000000000002951","volume":"40","author":"MDP Su\u00e1rez","year":"2024","unstructured":"Su\u00e1rez MDP, Fern\u00e1ndez-Sarmiento J, Gonz\u00e1lez LE et al (2024) Evaluation of the renal angina index to predict the development of acute kidney injury in children with sepsis who live in middle-income countries. Pediatr Emerg Care 40:208\u2013213. https:\/\/doi.org\/10.1097\/PEC.0000000000002951","journal-title":"Pediatr Emerg Care"},{"key":"7487_CR38","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1164\/rccm.201807-1346OC","volume":"199","author":"PK Bhatraju","year":"2019","unstructured":"Bhatraju PK, Zelnick LR, Herting J et al (2019) Identification of acute kidney injury subphenotypes with differing molecular signatures and responses to vasopressin therapy. Am J Respir Crit Care Med 199:863\u2013872. https:\/\/doi.org\/10.1164\/rccm.201807-1346OC","journal-title":"Am J Respir Crit Care Med"},{"key":"7487_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-020-02866-x","volume":"24","author":"R Wiersema","year":"2020","unstructured":"Wiersema R, Jukarainen S, Vaara ST et al (2020) Two subphenotypes of septic acute kidney injury are associated with different 90-day mortality and renal recovery. Crit Care 24:150. https:\/\/doi.org\/10.1186\/s13054-020-02866-x","journal-title":"Crit Care"},{"key":"7487_CR40","doi-asserted-by":"publisher","first-page":"e1000","DOI":"10.1097\/CCM.0000000000001833","volume":"44","author":"HR Wong","year":"2016","unstructured":"Wong HR, Atkinson SJ, Cvijanovich NZ et al (2016) Combining prognostic and predictive enrichment strategies to identify children with septic shock responsive to corticosteroids. Crit Care Med 44:e1000-1003. https:\/\/doi.org\/10.1097\/CCM.0000000000001833","journal-title":"Crit Care Med"},{"key":"7487_CR41","doi-asserted-by":"publisher","first-page":"e242","DOI":"10.1097\/CCM.0000000000002932","volume":"46","author":"HR Wong","year":"2018","unstructured":"Wong HR, Cvijanovich NZ, Anas N et al (2018) Endotype transitions during the acute phase of pediatric septic shock reflect changing risk and treatment response. Crit Care Med 46:e242\u2013e249. https:\/\/doi.org\/10.1097\/CCM.0000000000002932","journal-title":"Crit Care Med"},{"key":"7487_CR42","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1097\/PCC.0000000000003117","volume":"24","author":"JA Klowak","year":"2023","unstructured":"Klowak JA, Bijeli\u0107 V, Barrowman N et al (2023) The association of corticosteroids and pediatric sepsis biomarker risk model (PERSEVERE)-II biomarker risk stratification with mortality in pediatric septic shock. Pediatr Crit Care Med 24:186\u2013193. https:\/\/doi.org\/10.1097\/PCC.0000000000003117","journal-title":"Pediatr Crit Care Med"},{"key":"7487_CR43","doi-asserted-by":"publisher","first-page":"2878","DOI":"10.1097\/ccm.0b013e318186aa49","volume":"36","author":"TC Nguyen","year":"2008","unstructured":"Nguyen TC, Han YY, Kiss JE et al (2008) Intensive plasma exchange increases a disintegrin and metalloprotease with thrombospondin motifs-13 activity and reverses organ dysfunction in children with thrombocytopenia-associated multiple organ failure. Crit Care Med 36:2878\u20132887. https:\/\/doi.org\/10.1097\/ccm.0b013e318186aa49","journal-title":"Crit Care Med"},{"key":"7487_CR44","doi-asserted-by":"publisher","first-page":"e173","DOI":"10.1097\/CCM.0000000000003559","volume":"47","author":"JD Fortenberry","year":"2019","unstructured":"Fortenberry JD, Nguyen T, Grunwell JR et al (2019) Therapeutic plasma exchange in children with thrombocytopenia-associated multiple organ failure: the Thrombocytopenia-Associated Multiple Organ Failure Network prospective experience. Crit Care Med 47:e173\u2013e181. https:\/\/doi.org\/10.1097\/CCM.0000000000003559","journal-title":"Crit Care Med"},{"key":"7487_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-63121-9","volume":"14","author":"AJ Westover","year":"2024","unstructured":"Westover AJ, Humes HD, Pino CJ (2024) Immunomodulatory effects of a cell processing device to ameliorate dysregulated hyperinflammatory disease states. Sci Rep 14:12747. https:\/\/doi.org\/10.1038\/s41598-024-63121-9","journal-title":"Sci Rep"},{"key":"7487_CR46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0132482","volume":"10","author":"JA Tumlin","year":"2015","unstructured":"Tumlin JA, Galphin CM, Tolwani AJ et al (2015) A multi-center, randomized, controlled, pivotal study to assess the safety and efficacy of a selective cytopheretic device in patients with acute kidney injury. PLoS One 10:e0132482. https:\/\/doi.org\/10.1371\/journal.pone.0132482","journal-title":"PLoS ONE"},{"key":"7487_CR47","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1007\/s00467-022-05692-1","volume":"38","author":"SL Goldstein","year":"2023","unstructured":"Goldstein SL, Yessayan LT, Krallman KA et al (2023) Use of extracorporeal immunomodulation in a toddler with hemophagocytic lymphohistiocytosis and multisystem organ failure. Pediatr Nephrol 38:927\u2013931. https:\/\/doi.org\/10.1007\/s00467-022-05692-1","journal-title":"Pediatr Nephrol"},{"key":"7487_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.xkme.2024.100792","volume":"6","author":"SL Goldstein","year":"2024","unstructured":"Goldstein SL, Ollberding NJ, Askenazi DJ et al (2024) Selective cytopheretic device use in continuous kidney replacement therapy in children: a cohort study with a historical comparator. Kidney Med 6:100792. https:\/\/doi.org\/10.1016\/j.xkme.2024.100792","journal-title":"Kidney Med"},{"key":"7487_CR49","doi-asserted-by":"publisher","DOI":"10.1159\/000549111","author":"NL Stanski","year":"2025","unstructured":"Stanski NL, Seo J, Jenkins T et al (2025) Use of the selective cytopheretic device with continuous renal replacement therapy in children: a comparison of contemporary cohorts. Blood Purif. https:\/\/doi.org\/10.1159\/000549111","journal-title":"Blood Purif"},{"key":"7487_CR50","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1164\/rccm.202410-1924OC","volume":"211","author":"M Legrand","year":"2025","unstructured":"Legrand M, Jullien E, Kimmoun A et al (2025) Iloprost for the treatment of severe septic shock with persistent hypoperfusion: a double-blind, randomized controlled trial. Am J Respir Crit Care Med 211:1211\u20131219. https:\/\/doi.org\/10.1164\/rccm.202410-1924OC","journal-title":"Am J Respir Crit Care Med"},{"key":"7487_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinane.2022.110960","volume":"83","author":"H Hu","year":"2022","unstructured":"Hu H, An S, Sha T et al (2022) Association between dexmedetomidine administration and outcomes in critically ill patients with sepsis-associated acute kidney injury. J Clin Anesth 83:110960. https:\/\/doi.org\/10.1016\/j.jclinane.2022.110960","journal-title":"J Clin Anesth"},{"key":"7487_CR52","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1186\/s10020-024-00964-y","volume":"30","author":"S Zhang","year":"2024","unstructured":"Zhang S, Feng X, Yang G et al (2024) Dexmedetomidine ameliorates acute kidney injury by regulating mitochondrial dynamics via the \u03b12-AR\/SIRT1\/PGC-1\u03b1 pathway activation in rats. Mol Med 30:184. https:\/\/doi.org\/10.1186\/s10020-024-00964-y","journal-title":"Mol Med"},{"key":"7487_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-026-03953-5","author":"B Liu","year":"2026","unstructured":"Liu B, Ao S, Luo L et al (2026) Dexmedetomidine alleviates sepsis-associated acute kidney injury by inhibiting renal tubular ferroptosis via JNK\/MAPK-LCN2 pathway. Eur J Med Res. https:\/\/doi.org\/10.1186\/s40001-026-03953-5","journal-title":"Eur J Med Res"},{"key":"7487_CR54","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1016\/j.kint.2019.06.013","volume":"96","author":"YR Lankadeva","year":"2019","unstructured":"Lankadeva YR, Ma S, Iguchi N et al (2019) Dexmedetomidine reduces norepinephrine requirements and preserves renal oxygenation and function in ovine septic acute kidney injury. Kidney Int 96:1150\u20131161. https:\/\/doi.org\/10.1016\/j.kint.2019.06.013","journal-title":"Kidney Int"},{"key":"7487_CR55","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2023-081120","volume":"14","author":"IE Saraiva","year":"2024","unstructured":"Saraiva IE, Hamahata N, Huang DT et al (2024) Metformin for sepsis-associated AKI: a protocol for the randomized clinical trial of the safety and feasibility of metformin as a treatment for sepsis-associated AKI (LiMiT AKI). BMJ Open 14:e081120. https:\/\/doi.org\/10.1136\/bmjopen-2023-081120","journal-title":"BMJ Open"},{"key":"7487_CR56","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1097\/CCM.0000000000003092","volume":"46","author":"JA Tumlin","year":"2018","unstructured":"Tumlin JA, Murugan R, Deane AM et al (2018) Outcomes in patients with vasodilatory shock and renal replacement therapy treated with intravenous angiotensin II. Crit Care Med 46:949\u2013957. https:\/\/doi.org\/10.1097\/CCM.0000000000003092","journal-title":"Crit Care Med"},{"key":"7487_CR57","doi-asserted-by":"publisher","DOI":"10.1097\/CCE.0000000000000978","volume":"5","author":"O Tezel","year":"2023","unstructured":"Tezel O, Hutson TK, Gist KM et al (2023) Utilization of synthetic human angiotensin II for catecholamine-resistant vasodilatory shock in critically ill children: a single-center retrospective case series. Crit Care Explor 5:e0978. https:\/\/doi.org\/10.1097\/CCE.0000000000000978","journal-title":"Crit Care Explor"},{"key":"7487_CR58","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002243.pub5","volume":"6","author":"D Annane","year":"2025","unstructured":"Annane D, Briegel J, Granton D et al (2025) Corticosteroids for treating sepsis in children and adults. Cochrane Database Syst Rev 6:CD002243. https:\/\/doi.org\/10.1002\/14651858.CD002243.pub5","journal-title":"Cochrane Database Syst Rev"},{"key":"7487_CR59","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2025.12279","volume":"8","author":"LH Donaldson","year":"2025","unstructured":"Donaldson LH, Devaux A, White KC et al (2025) Hydrocortisone and risk factors for kidney replacement therapy in septic shock. JAMA Netw Open 8:e2512279. https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.12279","journal-title":"JAMA Netw Open"},{"key":"7487_CR60","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1097\/CCM.0000000000001402","volume":"44","author":"B Shakoory","year":"2016","unstructured":"Shakoory B, Carcillo JA, Chatham WW et al (2016) Interleukin-1 receptor blockade is associated with reduced mortality in sepsis patients with features of macrophage activation syndrome: reanalysis of a prior phase III trial. Crit Care Med 44:275\u2013281. https:\/\/doi.org\/10.1097\/CCM.0000000000001402","journal-title":"Crit Care Med"},{"key":"7487_CR61","doi-asserted-by":"publisher","DOI":"10.3390\/cells14060441","volume":"14","author":"E-P Lee","year":"2025","unstructured":"Lee E-P, Lin J-J, Chen S-H et al (2025) Clinical value of tocilizumab in reducing mortality in refractory septic shock in children with hematologic and non-hematologic diseases. Cells 14:441. https:\/\/doi.org\/10.3390\/cells14060441","journal-title":"Cells"},{"key":"7487_CR62","doi-asserted-by":"publisher","first-page":"e635","DOI":"10.1097\/PCC.0000000000003332","volume":"24","author":"JM VanBuren","year":"2023","unstructured":"VanBuren JM, Hall M, Zuppa AF et al (2023) The design of nested adaptive clinical trials of multiple organ dysfunction syndrome children in a single study. Pediatr Crit Care Med 24:e635\u2013e646. https:\/\/doi.org\/10.1097\/PCC.0000000000003332","journal-title":"Pediatr Crit Care Med"},{"key":"7487_CR63","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/S2213-2600(26)00047-0","volume":"14","author":"JA Neyra","year":"2026","unstructured":"Neyra JA, Legrand M, Tidswell MA et al (2026) Polymyxin B haemoadsorption in endotoxic septic shock (Tigris): a multicentre, open-label, Bayesian, randomised, controlled, phase 3 trial. Lancet Respir Med 14:443\u2013452. https:\/\/doi.org\/10.1016\/S2213-2600(26)00047-0","journal-title":"Lancet Respir Med"},{"key":"7487_CR64","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1186\/cc5064","volume":"10","author":"TC Nguyen","year":"2006","unstructured":"Nguyen TC, Carcillo JA (2006) Bench-to-bedside review: thrombocytopenia-associated multiple organ failure\u2013a newly appreciated syndrome in the critically ill. Crit Care 10:235. https:\/\/doi.org\/10.1186\/cc5064","journal-title":"Crit Care"},{"key":"7487_CR65","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s00134-019-05878-6","volume":"46","author":"SL Weiss","year":"2020","unstructured":"Weiss SL, Peters MJ, Alhazzani W et al (2020) Surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children. Intensive Care Med 46:10\u201367. https:\/\/doi.org\/10.1007\/s00134-019-05878-6","journal-title":"Intensive Care Med"},{"key":"7487_CR66","doi-asserted-by":"publisher","first-page":"e897","DOI":"10.1097\/CCM.0000000000001735","volume":"44","author":"J Kosaka","year":"2016","unstructured":"Kosaka J, Lankadeva YR, May CN, Bellomo R (2016) Histopathology of septic acute kidney injury: a systematic review of experimental data. Crit Care Med 44:e897-903. https:\/\/doi.org\/10.1097\/CCM.0000000000001735","journal-title":"Crit Care Med"},{"key":"7487_CR67","doi-asserted-by":"publisher","DOI":"10.1111\/micc.12483","volume":"26","author":"S Ma","year":"2019","unstructured":"Ma S, Evans RG, Iguchi N et al (2019) Sepsis-induced acute kidney injury: a disease of the microcirculation. Microcirculation 26:e12483. https:\/\/doi.org\/10.1111\/micc.12483","journal-title":"Microcirculation (New York, NY : 1994)"},{"key":"7487_CR68","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/j.kint.2019.05.026","volume":"96","author":"S Peerapornratana","year":"2019","unstructured":"Peerapornratana S, Manrique-Caballero CL, G\u00f3mez H, Kellum JA (2019) Acute kidney injury from sepsis: current concepts, epidemiology, pathophysiology, prevention and treatment. Kidney Int 96:1083\u20131099. https:\/\/doi.org\/10.1016\/j.kint.2019.05.026","journal-title":"Kidney Int"},{"key":"7487_CR69","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1097\/SHK.0b013e318240b52a","volume":"37","author":"H-W Hsiao","year":"2012","unstructured":"Hsiao H-W, Tsai K-L, Wang L-F et al (2012) The decline of autophagy contributes to proximal tubular dysfunction during sepsis. Shock 37:289\u2013296. https:\/\/doi.org\/10.1097\/SHK.0b013e318240b52a","journal-title":"Shock"},{"key":"7487_CR70","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06826-z","volume":"15","author":"T Li","year":"2024","unstructured":"Li T, Qu J, Hu C et al (2024) Macrophage migration inhibitory factor (MIF) suppresses mitophagy through disturbing the protein interaction of PINK1-Parkin in sepsis-associated acute kidney injury. Cell Death Dis 15:473. https:\/\/doi.org\/10.1038\/s41419-024-06826-z","journal-title":"Cell Death Dis"},{"key":"7487_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2025.114741","volume":"157","author":"C Hu","year":"2025","unstructured":"Hu C, Wu Z, Li T et al (2025) Dendrobine attenuates sepsis-associated acute kidney injury by promoting PINK1\/PARKIN-mediated mitophagy. Int Immunopharmacol 157:114741. https:\/\/doi.org\/10.1016\/j.intimp.2025.114741","journal-title":"Int Immunopharmacol"},{"key":"7487_CR72","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1159\/000520698","volume":"146","author":"N Pabla","year":"2022","unstructured":"Pabla N, Bajwa A (2022) Role of mitochondrial therapy for ischemic-reperfusion injury and acute kidney injury. Nephron 146:253\u2013258. https:\/\/doi.org\/10.1159\/000520698","journal-title":"Nephron"},{"key":"7487_CR73","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-023-04739-5","volume":"27","author":"B Garcia","year":"2023","unstructured":"Garcia B, Zarbock A, Bellomo R, Legrand M (2023) The alternative renin-angiotensin system in critically ill patients: pathophysiology and therapeutic implications. Crit Care 27:453. https:\/\/doi.org\/10.1186\/s13054-023-04739-5","journal-title":"Crit Care"},{"key":"7487_CR74","doi-asserted-by":"publisher","first-page":"339","DOI":"10.2147\/JEP.S297682","volume":"13","author":"SS Quadri","year":"2021","unstructured":"Quadri SS, Cooper C, Ghaffar D et al (2021) The pathological role of pro(renin) receptor in renal inflammation. J Exp Pharmacol 13:339\u2013344. https:\/\/doi.org\/10.2147\/JEP.S297682","journal-title":"J Exp Pharmacol"},{"key":"7487_CR75","doi-asserted-by":"publisher","DOI":"10.1186\/cc8887","volume":"14","author":"KC Doerschug","year":"2010","unstructured":"Doerschug KC, Delsing AS, Schmidt GA, Ashare A (2010) Renin-angiotensin system activation correlates with microvascular dysfunction in a prospective cohort study of clinical sepsis. Crit Care 14:R24. https:\/\/doi.org\/10.1186\/cc8887","journal-title":"Crit Care"},{"key":"7487_CR76","doi-asserted-by":"publisher","first-page":"H137","DOI":"10.1152\/ajpheart.00618.2015","volume":"310","author":"MC Chappell","year":"2016","unstructured":"Chappell MC (2016) Biochemical evaluation of the renin-angiotensin system: the good, bad, and absolute? Am J Physiol Heart Circ Physiol 310:H137-152. https:\/\/doi.org\/10.1152\/ajpheart.00618.2015","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"7487_CR77","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1164\/rccm.201911-2172OC","volume":"202","author":"R Bellomo","year":"2020","unstructured":"Bellomo R, Forni LG, Busse LW et al (2020) Renin and survival in patients given angiotensin II for catecholamine-resistant vasodilatory shock. A clinical trial. Am J Respir Crit Care Med 202:1253\u20131261. https:\/\/doi.org\/10.1164\/rccm.201911-2172OC","journal-title":"Am J Respir Crit Care Med"},{"key":"7487_CR78","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-020-2733-x","volume":"24","author":"R Bellomo","year":"2020","unstructured":"Bellomo R, Wunderink RG, Szerlip H et al (2020) Angiotensin I and angiotensin II concentrations and their ratio in catecholamine-resistant vasodilatory shock. Crit Care 24:43. https:\/\/doi.org\/10.1186\/s13054-020-2733-x","journal-title":"Crit Care"},{"key":"7487_CR79","doi-asserted-by":"publisher","DOI":"10.1186\/cc8185","volume":"13","author":"L Wan","year":"2009","unstructured":"Wan L, Langenberg C, Bellomo R, May CN (2009) Angiotensin II in experimental hyperdynamic sepsis. Crit Care 13:R190. https:\/\/doi.org\/10.1186\/cc8185","journal-title":"Crit Care"},{"key":"7487_CR80","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-023-04396-8","volume":"27","author":"B Garcia","year":"2023","unstructured":"Garcia B, Su F, Manicone F et al (2023) Angiotensin 1-7 in an experimental septic shock model. Crit Care 27:106. https:\/\/doi.org\/10.1186\/s13054-023-04396-8","journal-title":"Crit Care"},{"key":"7487_CR81","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.1016\/j.ekir.2023.09.019","volume":"8","author":"SL Goldstein","year":"2023","unstructured":"Goldstein SL, Krallman KA, Roy J-P et al (2023) Real-time acute kidney injury risk stratification-biomarker directed fluid management improves outcomes in critically ill children and young adults. Kidney Int Rep 8:2690\u20132700. https:\/\/doi.org\/10.1016\/j.ekir.2023.09.019","journal-title":"Kidney Int Rep"},{"key":"7487_CR82","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1213\/ANE.0000000000005458","volume":"133","author":"A Zarbock","year":"2021","unstructured":"Zarbock A, K\u00fcllmar M, Ostermann M et al (2021) Prevention of cardiac surgery-associated acute kidney injury by implementing the KDIGO guidelines in high-risk patients identified by biomarkers: the PrevAKI-multicenter randomized controlled trial. Anesth Analg 133:292\u2013302. https:\/\/doi.org\/10.1213\/ANE.0000000000005458","journal-title":"Anesth Analg"},{"key":"7487_CR83","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1097\/SLA.0000000000002485","volume":"267","author":"I G\u00f6cze","year":"2018","unstructured":"G\u00f6cze I, Jauch D, G\u00f6tz M et al (2018) Biomarker-guided intervention to prevent acute kidney injury after major surgery: the prospective randomized BigpAK study. Ann Surg 267:1013\u20131020. https:\/\/doi.org\/10.1097\/SLA.0000000000002485","journal-title":"Ann Surg"},{"key":"7487_CR84","doi-asserted-by":"publisher","first-page":"888","DOI":"10.3390\/cimb47110888","volume":"47","author":"Z Zhang","year":"2025","unstructured":"Zhang Z, Sheng M, Bao Y, Tang C (2025) Research progress on signalling pathways related to sepsis-associated acute kidney injury in children. Curr Issues Mol Biol 47:888. https:\/\/doi.org\/10.3390\/cimb47110888","journal-title":"Curr Issues Mol Biol"},{"key":"7487_CR85","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1007\/s00134-024-07560-y","volume":"50","author":"A Zarbock","year":"2024","unstructured":"Zarbock A, Forni LG, Koyner JL et al (2024) Recommendations for clinical trial design in acute kidney injury from the 31st acute disease quality initiative consensus conference. A consensus statement. Intensive Care Med 50:1426\u20131437. https:\/\/doi.org\/10.1007\/s00134-024-07560-y","journal-title":"Intensive Care Med"},{"key":"7487_CR86","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41581-023-00758-1","volume":"20","author":"A Zarbock","year":"2024","unstructured":"Zarbock A, Forni LG, Ostermann M et al (2024) Designing acute kidney injury clinical trials. Nat Rev Nephrol 20:137\u2013146. https:\/\/doi.org\/10.1038\/s41581-023-00758-1","journal-title":"Nat Rev Nephrol"},{"key":"7487_CR87","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1093\/ndt\/gfac003","volume":"38","author":"D Lazzareschi","year":"2023","unstructured":"Lazzareschi D, Mehta RL, Dember LM et al (2023) Overcoming barriers in the design and implementation of clinical trials for acute kidney injury: a report from the 2020 Kidney Disease Clinical Trialists meeting. Nephrol Dial Transplant 38:834\u2013844. https:\/\/doi.org\/10.1093\/ndt\/gfac003","journal-title":"Nephrol Dial Transplant"},{"key":"7487_CR88","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1097\/MCC.0000000000000990","volume":"28","author":"RT Tallarico","year":"2022","unstructured":"Tallarico RT, Neto AS, Legrand M (2022) Pragmatic platform trials to improve the outcome of patients with acute kidney injury. Curr Opin Crit Care 28:622\u2013629. https:\/\/doi.org\/10.1097\/MCC.0000000000000990","journal-title":"Curr Opin Crit Care"},{"key":"7487_CR89","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-023-04717-x","volume":"27","author":"G Tomlinson","year":"2023","unstructured":"Tomlinson G, Al-Khafaji A, Conrad SA et al (2023) Bayesian methods: a potential path forward for sepsis trials. Crit Care 27:432. https:\/\/doi.org\/10.1186\/s13054-023-04717-x","journal-title":"Crit Care"},{"key":"7487_CR90","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01502","volume":"9","author":"VB Talisa","year":"2018","unstructured":"Talisa VB, Yende S, Seymour CW, Angus DC (2018) Arguing for adaptive clinical trials in sepsis. Front Immunol 9:1502. https:\/\/doi.org\/10.3389\/fimmu.2018.01502","journal-title":"Front Immunol"},{"key":"7487_CR91","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.25f15796","volume":"86","author":"C Andrade","year":"2025","unstructured":"Andrade C (2025) Target trial emulation: a concept simply explained. J Clin Psychiatry 86:25f15796. https:\/\/doi.org\/10.4088\/JCP.25f15796","journal-title":"J Clin Psychiatry"},{"key":"7487_CR92","doi-asserted-by":"publisher","DOI":"10.1016\/j.semnephrol.2025.151665","volume":"45","author":"JD Odum","year":"2025","unstructured":"Odum JD, Hasson DC, Stanski NL et al (2025) The clinical view of sepsis-associated AKI: how basic science can help solve this problem. Semin Nephrol 45:151665. https:\/\/doi.org\/10.1016\/j.semnephrol.2025.151665","journal-title":"Semin Nephrol"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-026-07487-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-026-07487-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-026-07487-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T01:23:38Z","timestamp":1784856218000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-026-07487-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,24]]},"references-count":92,"alternative-id":["7487"],"URL":"https:\/\/doi.org\/10.1007\/s00467-026-07487-0","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,24]]},"assertion":[{"value":"20 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"NLS has a pending patent for the PERSEVERE-II AKI prediction model. All other authors have no relevant competing interests to disclose.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}